The Simplexa COVID-19/Flu A/B & RSV Direct Kit is used for the detection and differentiation of infections with SARS-CoV-2, flu A/B, and respiratory syncytial viruses.
Study proves strong impact of taking molecular TB diagnostics closer to the people. Urgent call to replace sputum microscopy completely with true point-of-care molecular tests to #FindAllTB An ...
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...
AI-driven diagnostic efficiency streamlines lab test selection, reducing clinician workload and enhancing patient care at health systems.
India-specific database of Coronary Artery Diseases will help identify if a person has a risk factor of developing heart ...
An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people. This multi-country randomised controlled study ...
New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagnostics ...
NEW YORK – With a new focus on cancer companion diagnostics, Biocartis aims to expand the menu for its automated molecular testing business to drive uptake of the Idylla system, following the recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback